Related Experiment Video
Updated: Jun 28, 2026
10:04
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Practical considerations for multiple myeloma: an overview of recent data and current options
1Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA. sloni01@emory.edu
Clinical Lymphoma & Myeloma
|November 1, 2008
Summary
Novel agents significantly improve treatment outcomes for multiple myeloma (MM). Promising combinations are now used in induction therapy, showing impressive responses and potential survival benefits.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- Multiple myeloma (MM) treatment landscape has evolved with novel agents.
- These agents demonstrate improved response rates and survival benefits in MM.
Purpose of the Study:
- To review promising novel agent combinations for MM induction therapy.
- To discuss emerging agents for relapsed MM.
Main Methods:
- Literature review of novel agents in multiple myeloma.
- Analysis of data on induction and relapsed/refractory MM treatment.
Main Results:
- Novel agents show impressive responses in MM induction therapy.
- Bortezomib and lenalidomide are effective in relapsed/refractory MM and induction settings.
Conclusions:
- Novel agent combinations represent a significant advancement in MM induction therapy.
- Ongoing research into new agents holds promise for relapsed MM.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...